▲ Peaking Business Regeneron backs $75M series A for antibody upstart Infinimmune Biotech startup Infinimmune has secured $75 million in Series A funding backed by Regeneron to develop antibodies for atopic dermatitis and inflammatory disease. 5 sources 5 articles v 3 2h ago
◼ Archived Business 🔮 fades Sanofi abandons plan to seek approval for eczema drug from $1.1B Kymab buyout Sanofi is scrapping plans for an eczema drug derived from its billion-dollar Kymab acquisition following a strategic pipeline review. 5 sources 5 articles v 3 18d ago